MetaCap

Who Owns Immunocore Stock?

NASDAQ: IMCRHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

26.41-0.22 (-0.83%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Ownership breakdown

Held by institutions
103.41%
Institutional holders
174
  • Institutions 99.9%
  • Insiders 0.1%
  • Public and other 0.0%

Who owns Immunocore stock?

Institutional investors own about 103.4% of Immunocore's shares, spread across 174 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 0.07% of IMCR.

The largest institutional holders are Wellington Management Group, LLP (11.06%), RTW Investments LP (9.42%) and Primecap Management Company (7.04%). Together, the top 10 institutions control 54.6% of shares outstanding. In their latest filings, 5 of the top 10 institutions increased their IMCR positions and 4 reduced them.

Summary generated from market data by MetaCap's automated system. Methodology

Top institutional holders of IMCR

Immunocore top institutional holders
InstitutionShares% HeldChange
Wellington Management Group, LLP5.72M11.06%-0.1%
RTW Investments LP4.87M9.42%0.0%
Primecap Management Company3.64M7.04%-0.1%
Tang Capital Management, LLC2.88M5.58%+8.9%
Bellevue Group AG2.26M4.38%-18.8%
Two Sigma Investments, LP2.02M3.90%+22.2%
Acadian Asset Management. LLC1.82M3.53%+50.8%
FMR, LLC1.74M3.36%-59.7%
Caligan Partners, LP1.67M3.24%+21.1%
Millennium Management Llc1.60M3.09%+29.1%

% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.

Top mutual fund and ETF holders of IMCR

Immunocore top fund holders
FundShares% Held
VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund4.25M8.22%
VANGUARD HORIZON FUNDS-Vanguard Capital Opportunity Fund2.34M4.52%
PRIMECAP Odyssey Funds-PRIMECAP Odyssey Aggressive Growth Fund1.11M2.15%
T. Rowe Price Health Sciences Fund, Inc.645.27K1.25%
Fidelity Select Portfolios-Select Health Care Portfolio500.00K0.97%
BlackRock Health Sciences Term Trust359.13K0.69%
iShares Trust-iShares Biotechnology ETF353.56K0.68%
Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund324.82K0.63%
MFS SERIES TRUST I-MFS New Discovery Fund304.30K0.59%
Fidelity Advisor Series VII-Fidelity Advisor Health Care Fund260.00K0.50%

Frequently asked questions

Who is the largest shareholder of Immunocore?

Wellington Management Group, LLP is the largest institutional shareholder of IMCR, owning 11.06% of shares outstanding (5.72M shares) as of its latest 13F filing.

What percentage of Immunocore is owned by institutions?

Institutions own about 103.4% of IMCR shares and 103.5% of the public float.

How much of Immunocore do insiders own?

Insiders, such as officers and directors, own about 0.07% of IMCR shares outstanding.

Where does institutional ownership data come from?

Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.

Related